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Brazil has several challenges to strengthen the biopharmaceutical industry, one of them particularly regarding 
the ability to translate scientific research into products. Many scholars have been working on this issue and the 
causalities involved on it in order to contribute to a better understanding of interrelationship between micro and 
macroeconomic dynamics. Most of the studies are directed to private organizations based in developed 
countries and aimed to understand the factors of success. Despite the wealth of these approaches, there are 
few studies about the challenges involved in the transitions from preclinical to clinical stage in the process of 
Research and Development in developing countries. There are gaps in the understanding of these steps, 
especially with respect to the requirement to move from the bench to the pilot scale. The main objective of a 
pilot plant in the biopharmaceutical industry is to demonstrate, with scientific and technological data, the 
feasibility of a candidate product being transformed into a pilot batch in a GMP certified area. For that, it is 
necessary to obtain data on yield, reproducibility, repeatability of the established processes, physicochemical 
stability and thermal stability of the candidate antigen or molecule, formulation parameters and process 
scheduling. In view of this fact, the present work addresses the issue of industrial pilot plants areas in 
developing countries from the application of business models approach. The literature about business models 
provide a practical reference able to assist other organizations to outline the value proposition and to analyze 
the critical factors for success implementation of pilot plants. This work aims to contribute to the discussion of 
this topic in Brazil due to the ongoing initiatives for the implementation of pilot plants and to serve as subsidies 
for public policy. Considering the scenario of the biopharmaceutical industries, where the dynamics of 
biotechnological and economic transformations has been shown to be complex for the evolution of the product 
development cycle, Brazil needs not only to improve its infrastructure for Research and Development but also to 
design and implement appropriate business models for the components of this infrastructure. 
 
